Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWSSYA10-001 is an inhibitor of severe acute respiratory syndrome coronavirus (SARS-CoV) helicase nsp13 (IC50s = 5.3 and 5.7 µM for dsDNA and dsRNA, respectively) and the protein-protein interaction between human papillomavirus (HPV) E6 and E6-associated proteins (E6-AP; IC50 = 10 µM).1,2,3 It is selective for SARS-CoV nsp13 over hepatitis C virus (HCV) and dengue virus helicases at 2 µM.1 SSYA10-001 inhibits the replication of SARS-CoV in HEK293T cells, Middle East respiratory syndrome CoV (MERS-CoV) in Vero E6 cells, and mouse hepatitis virus (MHV) in mouse WM-L2 fibroblasts (EC50s = 8.95, 25, and 12 µM, respectively).1,2 It decreases HPV E6-induced p53 degradation in SiHa and HeLa cells when used at concentrations of 1, 5, and 10 µM.3
WARNING This product is not for human or veterinary use.
1. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase. Antimicrob Agents Chemother. 56(9), 4718-4728 (2012).
2. Evaluation of SSYA10-
3. Identification and characterization of small molecule human papillomavirus E6 inhibitors. ACS Chem. Biol. 9(7), 1603-1612 (2014).